INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in HUTCHMED (China) Limited with Losses of $100,000 to Contact the Firm
apnews.com
business
2022-05-27 16:06:45

LOS ANGELES--(BUSINESS WIRE)--May 27, 2022--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HUTCHMED (China) Limited ('HUTCHMED' or 'the Company') (NASDAQ: HCM ) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. HUTCHMED announced on May 2, 2022, that the FDA had rejected the Company's application for surufatinib to treat certain neuroendocrine tumors.
